US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Mesa Laboratories Inc

us-stock
To Invest in {{usstockname}}
us-stock
$76.38 0.0042(0.42%) MLAB at 04 Dec 2025 04:38 PM Scientific & Technical Instruments
Lowest Today 76.135
Highest Today 77.91
Today’s Open 76.33
Prev. Close 76.06
52 Week High 154.03
52 Week Low 55.21
Day’s Range: Low 76.135 High 77.91
52-Week Range: Low 55.21 High 154.03
1 day return -
1 Week return -4.47
1 month return +3.51
3 month return +20.14
6 month return -24.14
1 year return -38.77
3 year return -56.14
5 year return -71.93
10 year return -

Institutional Holdings

BlackRock Inc 14.38

Conestoga Capital Advisors, LLC 10.29

Conestoga Small Cap Investors 7.35

Vanguard Group Inc 7.08

iShares Core S&P Small-Cap ETF 5.92

Royce & Associates, LP 4.50

Morgan Stanley - Brokerage Accounts 3.98

Ranger Investment Management LP 3.90

State Street Corp 3.85

Geneva Capital Management 3.62

Conestoga Small Cap Growth 3.30

Vanguard Total Stock Mkt Idx Inv 2.90

Ranger Small Cap 2.82

Glenmede Trust Co NA 2.66

Geode Capital Management, LLC 2.52

Glenmede Small Cap Equity 2.30

Glenmede Small Cap Equity Adv 2.30

iShares Russell 2000 ETF 2.26

Diamond Hill Small Cap Equity 2.21

Dimensional Fund Advisors, Inc. 2.10

HHG PLC 2.06

Diamond Hill Small Cap Inv 2.01

Janus Henderson Small Cap Value L 1.92

Select Equity Group LP 1.86

Royce Small-Cap Composite 1.74

Royce Small-Cap Fund Invmt 1.74

Royce Small-Cap Trust 1.69

Northern Trust Corp 1.69

Kennedy Capital Management Inc 1.64

Acadian Asset Management LLC 1.44

CT (Lux) Glb Smlr Coms IE 1.43

Kennedy Small Cap Value 1.41

Ameriprise Financial Inc 1.34

Nationwide Geneva Small Cap Gr Instl Svc 1.27

Renaissance Technologies Corp 1.24

Bank of America Corp 1.18

Multi-Manager Small Cap Eq Strat Inst 1.13

Charles Schwab Investment Management Inc 1.12

Vanguard Institutional Extnd Mkt Idx Tr 1.06

Eagle Small Cap Strategy (Vermont Team) 1.01

Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 1

Fundamentals

Market Cap 420.03 M

PB Ratio 2.4377

PE Ratio 0.0

Enterprise Value 605.05 M

Total Assets 433.35 M

Volume 114431

Company Financials

Annual Revenue FY25:240978000 241.0M, FY24:216187000 216.2M, FY23:219080000 219.1M, FY22:184335000 184.3M, FY21:133937000 133.9M

Annual Profit FY25:150870000 150.9M, FY24:133250000 133.3M, FY23:133693000 133.7M, FY22:109090000 109.1M, FY21:87014000 87.0M

Annual Net worth FY25:-1974000 -2.0M, FY24:-254246000 -254.2M, FY23:930000 0.9M, FY22:1871000 1.9M, FY21:3274000 3.3M

Quarterly Revenue Q3/2025:60737000 60.7M, Q2/2025:59543000 59.5M, Q1/2025:62135000 62.1M, Q4/2024:62840000 62.8M, Q3/2024:57833000 57.8M

Quarterly Profit Q3/2025:37331000 37.3M, Q2/2025:32494000 32.5M, Q1/2025:38412000 38.4M, Q4/2024:39754000 39.8M, Q3/2024:35455000 35.5M

Quarterly Net worth Q3/2025:2476000 2.5M, Q2/2025:4742000 4.7M, Q1/2025:-7114000 -7.1M, Q4/2024:-1676000 -1.7M, Q3/2024:3428000 3.4M

Fund house & investment objective

Company Information Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Organisation Scientific & Technical Instruments

Employees 730

Industry Scientific & Technical Instruments

CEO Mr. Gary M. Owens

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right